Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5799-75-7

Post Buying Request

5799-75-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5799-75-7 Usage

Description

6-BROMOTETRAZOLO[1,5-A]PYRIDINE is a heterocyclic chemical compound characterized by the molecular formula C5H3BrN4. It features a pyridine ring fused to a tetrazole ring, making it a valuable intermediate in the synthesis of pharmaceuticals and agrochemicals. This solid compound is also recognized for its potential antitumor and antimicrobial properties, and is commonly utilized in research and development as a building block for more complex organic compounds. Due to its potential health and environmental hazards, careful handling is advised.

Uses

Used in Pharmaceutical Industry:
6-BROMOTETRAZOLO[1,5-A]PYRIDINE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 6-BROMOTETRAZOLO[1,5-A]PYRIDINE serves as an intermediate in the production of agrochemicals, potentially enhancing crop protection and management through its incorporation into effective compounds.
Used in Research and Development:
6-BROMOTETRAZOLO[1,5-A]PYRIDINE is utilized as a building block in the creation of more complex organic compounds, driving innovation in organic chemistry and contributing to the advancement of new chemical entities.
Used in Antitumor Applications:
6-BROMOTETRAZOLO[1,5-A]PYRIDINE has been studied for its potential antitumor properties, making it a candidate for further research into cancer treatment and therapeutic interventions.
Used in Antimicrobial Applications:
Due to its potential antimicrobial properties, 6-BROMOTETRAZOLO[1,5-A]PYRIDINE is explored for use in antimicrobial agents, which could be beneficial in combating resistant strains of bacteria and other pathogens.

Check Digit Verification of cas no

The CAS Registry Mumber 5799-75-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,9 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5799-75:
(6*5)+(5*7)+(4*9)+(3*9)+(2*7)+(1*5)=147
147 % 10 = 7
So 5799-75-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H13N/c1-2-6-9-7-4-3-5-8-9/h1H,3-8H2

5799-75-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-prop-2-ynylpiperidine

1.2 Other means of identification

Product number -
Other names 1-(2-Propynyl)piperidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5799-75-7 SDS

5799-75-7Relevant articles and documents

Studies in Tertiary Amine Oxides. Part-II - Carbon-13 Nuclear Magnetic Resonance Spectra of Selected Acetylenic Amines, their N-Oxides and the Meisenheimer Rearrangement Products

Al-Iraqi, Mohammed,Al-Rawi, Jasim M. A.,Khuthier, Abdul-Hussain

, p. 161 - 165 (1980)

Carbon-13 NMR chemical shifts and 1J(CH3), 2J(CH) and 3J(CH) coupling constants of selected saturated nitrogen heterocyclic molecules containing the acetylenic moiety have been determined.These NMR parameters have also been determined for the corresponding N-oxides and the Meisenheimer rearrangement products, the O-allenylhydroxylamines.The effect of the N-oxidation on the chemical shifts of the ring and the acetylenic carbon atoms is discussed.

Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions

Huang, Guang,Solano, Claribel Murillo,Melendez, Joel,Yu-Alfonzo, Sabrina,Boonhok, Rachasak,Min, Hui,Miao, Jun,Chakrabarti, Debopam,Yuan, Yu

supporting information, (2020/10/13)

To identity fast-acting, multistage antimalarial agents, a series of pyridylvinylquinoline-triazole analogues have been synthesized via CuAAC. Most of the compounds display significant inhibitory effect on the drug-resistant malarial Dd2 strain at low submicromolar concentrations. Among the tested analogues, compound 60 is the most potent molecule with an EC50 value of 0.04 ± 0.01 μM. Our current study indicates that compound 60 is a fast-acting antimalarial compound and it demonstrates stage specific action at the trophozoite phase in the P. falciparum asexual life cycle. In addition, compound 60 is active against both early and late stage P. falciparum gametocytes. From a mechanistic perspective, compound 60 shows good activity as an inhibitor of β-hematin formation. Collectively, our findings suggest that fast-acting agent 60 targets dual life stages of the malarial parasites and warrant further investigation of pyridylvinylquinoline hybrids as new antimalarials.

Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents

Zhang, Zhe,Li, Kang,Zhang, Guang-Yu,Tang, You-Zhi,Jin, Zhen

, (2020/07/30)

A series of novel pleuromutilin derivatives possessing 1,2,3-triazole moieties were synthesized via click reactions under mild conditions. The in vitro antibacterial activities of these derivatives against 4 strains of S. aureus (MRSA ATCC 43300, ATCC 29213, AD 3, and 144) and 1 strain of E. coli (ATCC 25922) were tested by the broth dilution method. The majority of the synthesized derivatives displayed potent antibacterial activities against MRSA (MIC = 0.125–2 μg/mL). It was also found that most compounds had no significant inhibitory effect on the proliferation of RAW264.7 cells at the concentration of 8 μg/mL. Among these derivatives, compound 32 (~1.71 log10 CFU/g) containing dimethylamine group side chain displayed more effective than tiamulin (~0.77 log10 CFU/g) at the dose of 20 mg/kg in reducing MRSA load in thigh infected mice. Additionally, compound 32 (the survival rate was 50%) also displayed superior in vivo efficacy to that of tiamulin (the survival rate was 20%) in the mouse systemic model. Structure-activity relationship (SAR) studies resulted in compound 32 with the most potent in vitro and in vivo antibacterial activity among the series. Moreover, compound 32 was evaluated in CYP450 inhibition assay and showed moderate in vitro inhibition of CYP3A4 (IC50 = 6.148 μM).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5799-75-7